Provided by Tiger Fintech (Singapore) Pte. Ltd.

Castle Biosciences, Inc.

20.09
-0.5400-2.62%
Post-market: 20.090.00000.00%16:20 EDT
Volume:489.24K
Turnover:9.81M
Market Cap:579.49M
PE:32.40
High:20.82
Open:20.66
Low:19.62
Close:20.63
Loading ...
Feb 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Dec 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 04, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Dec 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 10, 2023

Major Issues Report

Form 8-K - Current report
Nov 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2023

Major Issues Report

Form 8-K - Current report
Aug 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 02, 2023

Major Issues Report

Form 8-K - Current report
Aug 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2023

Major Issues Report

Form 8-K - Current report
Jun 02, 2023

Major Issues Report

Form 8-K - Current report
May 04, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 04, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 03, 2023

Major Issues Report

Form 8-K - Current report
May 03, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]